Abstract
We report herein a case of bacteremic ascitic fluid infection in a liver transplant patient caused by a strain of Yersinia pseudotuberculosis serogroup I that lost the yersiniabactin core. The patient's outcome was favorable after a combined therapy with a third-generation cephalosporin and gentamicin.
Keywords:
Ascitic fluid infection; Bacteremia; Hepatic cirrhosis; Liver transplant; Third-generation cephalosporin; Yersinia pseudotuberculosis.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Ascitic Fluid / microbiology*
-
Bacteremia / diagnosis*
-
Bacteremia / drug therapy
-
Bacteremia / etiology
-
Cephalosporins / therapeutic use
-
Drug Therapy, Combination
-
Gentamicins / therapeutic use
-
Humans
-
Liver Transplantation*
-
Male
-
Middle Aged
-
Treatment Outcome
-
Yersinia pseudotuberculosis / isolation & purification*
-
Yersinia pseudotuberculosis Infections / diagnosis*
-
Yersinia pseudotuberculosis Infections / drug therapy
Substances
-
Anti-Bacterial Agents
-
Cephalosporins
-
Gentamicins